IDEAL Study: Blinded RCT for the Impact of AI Model for Cerebral Aneurysms Detection on Patients' Diagnosis and Outcomes
Recruiting
N/A
Interventional Study
Intracranial Aneurysm
CT Angiography
Deep Learning
Double Bind Interaction
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 6,450 (estimated)
- Sponsor
- Jinling Hospital, China · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study (IEDAL study) intends to prospectively enroll more than 6450 patients who will undergo head CT angiography (CTA) scanning in the outpatient clinic. It will be carried out in 21 hospitals in more than 10 provinces in China. The patient's head CTA images will be randomly assigned to the True-AI and Sham-AI group with a ratio of 1:1, and the patients and radiologists are unaware of the all…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adult inpatients and outpatients who are scheduled for head CTA scanning.
Exclusion Criteria:
* Age under 18 years.
* Patients with contraindications to CTA.
* Modified Rankin Scale (mRS) score \> 3.
* Refuse to sign informed consent.
* Participation in other clinical studie…
Contacts